Capital Base. The Borrower will maintain, as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31, 1998), a consolidated Capital Base of not less than $40,000,000.
Appears in 1 contract
Samples: Letter Agreement (Arqule Inc)
Capital Base. The Borrower will maintain, as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31June 30, 19981999), a consolidated Capital Base of which shall not be less than $40,000,00013,500,000.
Appears in 1 contract
Samples: Letter Agreement (Abiomed Inc)
Capital Base. The Borrower will maintain, maintain as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31June 30, 1998), 1997) a consolidated Capital Base of not less than $40,000,0002,200,000.
Appears in 1 contract
Samples: Augment Systems Inc
Capital Base. The Borrower will maintain, as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31, 1998), a consolidated Capital Base of not less than $40,000,00035,000,000.
Appears in 1 contract
Samples: Transkaryotic Therapies Inc
Capital Base. The Borrower will maintain, maintain as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31September 30, 1998), ) a consolidated Capital Base of not less which shall be equal to or greater than $40,000,00032,800,000.
Appears in 1 contract
Capital Base. The Borrower will maintain, as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31June 30, 19981999), a consolidated Capital Base of not less than $40,000,00060,000,000.
Appears in 1 contract
Samples: Geltex Pharmaceuticals Inc
Capital Base. The Borrower will maintain, as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31February 28, 19981997), a consolidated Capital Base of not less than $40,000,00020,000,000.
Appears in 1 contract
Samples: Genome Therapeutics Corp
Capital Base. The Borrower will maintain, as at the end of each fiscal quarter of the Borrower (commencing with its results as at December March 31, 19981997), a consolidated Capital Base of not less than $40,000,000.
Appears in 1 contract
Samples: Geltex Pharmaceuticals Inc
Capital Base. The Borrower will maintain, as at the end of each fiscal quarter of the Borrower (commencing with its results as at December 31September 30, 19981999), a consolidated Capital Base of not less than $40,000,00010,000,000.
Appears in 1 contract
Samples: Organogenesis Inc